4.6 Review

Tissue Penetration of Antimicrobials in Intensive Care Unit Patients: A Systematic Review-Part I

Related references

Note: Only part of the references are listed.
Review Chemistry, Medicinal

Population Pharmacokinetics of Colistin Methanesulfonate Sodium and Colistin in Critically Ill Patients: A Systematic Review

Mohd Shafie Zabidi et al.

Summary: Understanding the pharmacokinetics of colistin methanesulfonate sodium (CMS) and colistin in critically ill patients is crucial for optimizing dosage regimens. However, there is a lack of consensus on these parameters in this population, with discrepancies likely arising from various factors such as pathophysiological changes, differences in drug brands, and study methodologies. Personalized dosing of colistin is recommended due to the significant variability in plasma concentrations and pharmacokinetic parameters observed in these patients.

PHARMACEUTICALS (2021)

Review Anesthesiology

Prevention of Healthcare-associated Infections in Intensive Care Unit Patients

Michael Mazzeffi et al.

Summary: Healthcare-associated infections are a major concern for intensive care unit patients, and understanding evidence-based prevention strategies is crucial for optimizing patient outcomes.

ANESTHESIOLOGY (2021)

Article Pharmacology & Pharmacy

Population pharmacokinetics of vancomycin in patients with external ventricular drain-associated ventriculitis

Kris Oliver Jalusic et al.

Summary: In patients with EVD-associated ventriculitis, the pharmacokinetics of vancomycin were studied using a three-compartment model with linear elimination. Creatinine clearance and CSF lactate were found to be significant covariates affecting the total vancomycin plasma clearance and the clearance between the central and CSF compartments.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2021)

Article Infectious Diseases

Nosocomial infections associated to COVID-19 in the intensive care unit: clinical characteristics and outcome

Tommaso Bardi et al.

Summary: Co-infection of bacteria and fungi is common in ICU-admitted COVID-19 patients and usually presents as a severe form of infection, associated with a high mortality rate and longer ICU stay.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2021)

Article Critical Care Medicine

Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021

Laura Evans et al.

CRITICAL CARE MEDICINE (2021)

Article Infectious Diseases

Pragmatic options for dose optimization of ceftazidime/avibactam with aztreonam in complex patients

Marco Falcone et al.

Summary: This study investigated dosing strategies for aztreonam with avibactam in critically ill patients, finding that pragmatic and lower daily dose options are predicted for aztreonam and ceftazidime/avibactam when the eGFR is <90 mL/min.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)

Review Medicine, General & Internal

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

Matthew J. Page et al.

Summary: The PRISMA statement was designed to help systematic reviewers transparently report the purpose, methods, and findings of their reviews. The updated PRISMA 2020 statement includes new reporting guidance, a 27-item checklist, an abstract checklist, and revised flow diagrams for reviews.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Article Medical Laboratory Technology

Cerebrospinal Fluid Penetration of Vancomycin During Continuous Infusion Therapy in Patients with Nosocomial Ventriculitis

Felipe Francisco Tuon et al.

THERAPEUTIC DRUG MONITORING (2021)

Review Infectious Diseases

Pharmacokinetics of Non-β-Lactam β-Lactamase Inhibitors

Giacomo Luci et al.

Summary: The emergence of drug-resistant bacterial strains is a growing issue for treating severe infections, with efforts focusing on identifying new pharmacological agents. New beta-lactam-BLI combinations have shown effectiveness in treating complicated infections, with pharmacokinetics partly matching beta-lactams. However, comorbidities and severe changes in individual pathological conditions may complicate dose adaptation, and therapeutic drug monitoring protocols are suggested to personalize drug doses in intensive care settings.

ANTIBIOTICS-BASEL (2021)

Review Critical Care Medicine

Timing of antibiotic therapy in the ICU

Marin H. Kollef et al.

Summary: The timing of antibiotic administration is critical for survival in critically ill patients with severe infections, such as sepsis and septic shock. Delayed administration can lead to higher mortality rates, while the selection of appropriate antibiotics is also crucial for increasing survival.

CRITICAL CARE (2021)

Article Critical Care Medicine

Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper#

Mohd H. Abdul-Aziz et al.

INTENSIVE CARE MEDICINE (2020)

Review Pharmacology & Pharmacy

The management of anti-infective agents in intensive care units: the potential role of a 'fast' pharmacology

Dario Cattaneo et al.

EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2020)

Review Infectious Diseases

Teicoplanin and therapeutic drug monitoring: An update for optimal use in different patient populations

Federico Pea

JOURNAL OF INFECTION AND CHEMOTHERAPY (2020)

Letter Infectious Diseases

CSF concentration of ceftriaxone following high-dose administration: pharmacological data from two French cohorts

Paul Le Turnier et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2019)

Review Infectious Diseases

Antibiotic penetration into bone and joints: An updated review

Abrar K. Thabit et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2019)

Article Pharmacology & Pharmacy

Cefuroxime plasma and tissue concentrations in patients undergoing elective cardiac surgery: Continuous vs bolus application. A pilot study

Keso Skhirtladze-Dworschak et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2019)

Article Infectious Diseases

Plasma and interstitial fluid population pharmacokinetics of vancomycin in critically ill patients with sepsis

Jacob Abraham et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2019)

Review Infectious Diseases

Intrapulmonary pharmacokinetics of antibiotics used to treat nosocomial pneumonia caused by Gram-negative bacilli: A systematic review

Aaron J. Heffernan et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2019)

Article Critical Care Medicine

Daptomycin Plasma and CSF Levels in Patients with Healthcare-Associated Meningitis

S. Piva et al.

NEUROCRITICAL CARE (2019)

Article Microbiology

Penetration of Cefotaxime into Cerebrospinal Fluid in Neonates and Young Infants

Xing-Kai Chen et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)

Article Infectious Diseases

Plasma and CSF pharmacokinetics of meropenem in neonates and young infants: results from the NeoMero studies

Eva Germovsek et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)

Article Infectious Diseases

Comparison of piperacillin exposure in the lungs of critically ill patients and healthy volunteers

T. W. Felton et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2018)

Review Microbiology

Optimizing the Clinical Use of Vancomycin

Rocio Alvarez et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)

Article Pharmacology & Pharmacy

Pooled population pharmacokinetic model of imipenem in plasma and the lung epithelial lining fluid

J. G. Coen van Hasselt et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)

Article Infectious Diseases

Evaluation of the tissue diffusion capacity of antibiotics in lower limb ischaemia

Silvia Lozano-Alonso et al.

ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA (2016)

Article Pharmacology & Pharmacy

Population pharmacokinetics and probability of target attainment of meropenem in critically ill patients

Francesca Mattioli et al.

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2016)

Article Pharmacology & Pharmacy

Reporting Guidelines for Clinical Pharmacokinetic Studies: The ClinPK Statement

Salmaan Kanji et al.

CLINICAL PHARMACOKINETICS (2015)

Article Chemistry, Medicinal

Population Pharmacokinetics of Vancomycin in Postoperative Neurosurgical Patients

Xingang Li et al.

JOURNAL OF PHARMACEUTICAL SCIENCES (2015)

Article Infectious Diseases

Modelled target attainment after meropenem infusion in patients with severe nosocomial pneumonia: the PROMESSE study

Frederic Frippiat et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)

Article Microbiology

Penetration of Daptomycin into Bone and Synovial Fluid in Joint Replacement

D. Montange et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)

Article Pharmacology & Pharmacy

Pulmonary Penetration of Piperacillin and Tazobactam in Critically Ill Patients

T. W. Felton et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)

Article Pharmacology & Pharmacy

Pharmacokinetics of ceftriaxone in plasma and bone of patients undergoing hip or knee surgery

Ulrich Gergs et al.

JOURNAL OF PHARMACY AND PHARMACOLOGY (2014)

Review Infectious Diseases

Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions

Jason A. Roberts et al.

LANCET INFECTIOUS DISEASES (2014)

Article Microbiology

Daptomycin Concentrations in Valve Tissue and Vegetation in Patients with Bacterial Endocarditis

Carlo Tascini et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)

Article Microbiology

Tissue Pharmacokinetics of Cefazolin in Patients with Lower Limb Infections

Amira A. Bhalodi et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)

Review Pharmacology & Pharmacy

Clinical Pharmacokinetics of Antibacterials in Cerebrospinal Fluid

Antonello Di Paolo et al.

CLINICAL PHARMACOKINETICS (2013)

Article Orthopedics

Determination of cephazolin, ceftazidime, and ceftriaxone distribution in nucleus pulposus

Denglu Yan et al.

ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY (2012)

Article Infectious Diseases

Intrapulmonary penetration of ceftolozane/tazobactam and piperacillin/tazobactam in healthy adult subjects

Gurudatt Chandorkar et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)

Review Pharmacology & Pharmacy

Barrier mechanisms in the developing brain

Norman R. Saunders et al.

FRONTIERS IN PHARMACOLOGY (2012)

Article Microbiology

Penetration of Ertapenem into Muscle Measured by In Vivo Microdialysis in Mechanically Ventilated Patients

I. Boyadjiev et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)

Article Microbiology

Penetration of Meropenem into Epithelial Lining Fluid of Patients with Ventilator-Associated Pneumonia

T. P. Lodise et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)

Article Pharmacology & Pharmacy

Dosing of colistin-back to basic PK/PD

Phillip J. Bergen et al.

CURRENT OPINION IN PHARMACOLOGY (2011)

Article Infectious Diseases

Ceftriaxone bone penetration in patients with septic non-union of the tibia

Silvia Garazzino et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2011)

Letter Infectious Diseases

Ertapenem in plasma and peritoneal fluid from patients with severe intra-abdominal infections

Marie-Clemence Verdier et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)

Article Infectious Diseases

Extracellular concentrations of fosfomycin in lung tissue of septic patients

Veronika Matzi et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)

Article Infectious Diseases

Soft tissue and bone penetration abilities of daptomycin in diabetic patients with bacterial foot infections

Friederike Traunmueller et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)

Article Microbiology

Soft-Tissue Penetration of Ceftobiprole in Healthy Volunteers Determined by In Vivo Microdialysis

April Barbour et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)

Article Microbiology

Bone Penetration of Amoxicillin and Clavulanic Acid Evaluated by Population Pharmacokinetics and Monte Carlo Simulation

Cornelia B. Landersdorfer et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)

Review Critical Care Medicine

Pharmacokinetic issues for antibiotics in the critically ill patient

Jason A. Roberts et al.

CRITICAL CARE MEDICINE (2009)

Article Dentistry, Oral Surgery & Medicine

Concentrations of piperacillin-tazobactam in human jaw and hip bone

Bilal Al-Nawas et al.

JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY (2008)

Article Medicine, General & Internal

Blood-brain barrier penetration of cefepime after neurosurgery

Wang Jiang-fei et al.

CHINESE MEDICAL JOURNAL (2007)

Article Critical Care Medicine

Pharmacokinetics and lung concentrations of ertapenem in patients with ventilator-associated pneumonia

Emmanuel Boselli et al.

INTENSIVE CARE MEDICINE (2006)

Article Microbiology

Effectiveness of cephalosporins in the sputum of patients with nosocomial bronchopneumonia

Almos Klekner et al.

JOURNAL OF CLINICAL MICROBIOLOGY (2006)

Article Infectious Diseases

Intrapulmonary pharmacokinetics and pharmacodynamics of meropenem

JE Conte et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2005)

Article Microbiology

Antibiotic abscess penetration: Fosfomycin levels measured in pus and simulated concentration-time profiles

R Sauermann et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)

Article Infectious Diseases

Disposition of instilled versus nebulized tobramycin and imipenem in ventilated intensive care unit (ICU) patients

JR Badia et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)

Article Microbiology

In vivo pharmacodynamic activity of daptomycin

N Safdar et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)

Article Pharmacology & Pharmacy

Penetration of piperacillin and tazobactam into pneumonic human lung tissue measured by in vivo microdialysis

F Tomaselli et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)

Article Infectious Diseases

Target site penetration of fosfomycin in critically ill patients

C Joukhadar et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)

Article Oncology

Diffusion of cefepime into cancellous and cortical bone tissue

D Breilh et al.

JOURNAL OF CHEMOTHERAPY (2003)

Article Microbiology

Penetration of fosfomycin into inflammatory lesions in patients with cellulitis or diabetic foot syndrome

FJ Legat et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)

Article Infectious Diseases

Animal model pharmacokinetics and pharmacodynamics: a critical review

D Andes et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2002)

Article Oncology

Penetration of piperacillin/tazobactam (4 g/500 mg) into synovial tissue

E Boselli et al.

JOURNAL OF CHEMOTHERAPY (2002)

Article Microbiology

Distribution and antimicrobial activity of fosfomycin in the interstitial fluid of human soft tissues

M Frossard et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)

Article Infectious Diseases

Plasma, urine and skin pharmacokinetics of cefepime in burns patients

E Sampol et al.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2000)

Article Critical Care Medicine

Surgery and intensive care procedures affect the target site distribution of piperacillin

M Brunner et al.

CRITICAL CARE MEDICINE (2000)